16898-52-5 | 1,3-Bis(4-piperidyl)propane

Packsize	Purity	Availability	Price	Discounted Price
5g	97%	in stock	$14.00	$10.00
25g	97%	in stock	$31.00	$22.00

Description

• Catalog Number: AB57254
• Chemical Name: 1,3-Bis(4-piperidyl)propane
• CAS Number: 16898-52-5
• Molecular Formula: C13H26N2
• Molecular Weight: 210.3589
• MDL Number: MFCD00038013
• SMILES: C(CC1CCNCC1)CC1CCNCC1
• NSC Number: 96364

Computed Properties

• Complexity: 140
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 15
• Hydrogen Bond Acceptor Count: 2
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 4
• XLogP3: 2.5

Literature

• (Nitrato-κO,O')bis-(tryptanthrin-κN)silver(I).

  Acta crystallographica. Section E, Structure reports online 20120201

• catena-Poly[[(triaqua-cadmium)-μ-1,4-phenyl-enediacetato-κO,O':O'',O'''] dihydrate].

  Acta crystallographica. Section E, Structure reports online 20111201

• Synthesis and antileukemic activity of novel 4-(3-(piperidin-4-yl) propyl)piperidine derivatives.

  Chemical biology & drug design 20111001

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• 4,4'-Trimethyl-enedipiperidiniumbenzene-1,4-dicarboxyl-ate.

  Acta crystallographica. Section E, Structure reports online 20091101

• Transformation of a layered zinc phosphite to a three-dimensional open-framework structure with intersecting 16- and 12-ring channels.

  Inorganic chemistry 20090420

• Synthesis and antimicrobial activity of 1-benzhydryl-sulfonyl-4-(3-(piperidin-4-yl) propyl)piperidine derivatives against pathogens of Lycopersicon esculentum: a structure-activity evaluation study.

  Archives of pharmacal research 20090101

• 4,4'-(Propane-1,3-di-yl)dipiperidinium sulfate monohydrate.

  Acta crystallographica. Section E, Structure reports online 20080901

• Effect of heterocyclic based organoclays on the properties of polyimide-clay nanocomposites.

  Journal of nanoscience and nanotechnology 20050701

• Preparation and characterization of novel inorganic-organic hybrid materials containing rare, mixed-halide anions of bismuth(III).

  Inorganic chemistry 20041101

• Design and synthesis of RNA-specific groove-binding cations: implications for antiviral drug design.

  Journal of medicinal chemistry 19940415